Replies to post #23670 on Innovation Pharmaceuticals Inc (IPIX)

[1iftrue]

I was just thinking the same thing JB, how could families of cancer patients not leak out that they are still living from a Cellcuetix intervention, not possible I think.

[petemantx]

You are only talking 9 patients thru the first 3 cohorts. They may have some positive results but not overwhelming data that shows complete success. Their doctors will say it looks promising but I don't see them, the patients or families getting that much word out when everything is still in testing. They would look pretty bad saying they have the cure for cancer and then the bottom drops out of the testing. Don't think CTIX and DF have that much to worry about from that end as to leaking information. Maybe some very close friends but no media feeding frenzy.

That will end come ASCO. The presentation may not be much but the Q/A will stir the pot up nicely. IMO

[BonelessCat]

The rules of ASCO state that the abstract and presentation should not report preliminary results before the close of Phase 1. Presenters can include all pre-clinical data and state things like the Phase 1 tests so far are in line with results from animal testing, but specific information and data about PK/PD and efficacy can't be included.

Kevetrin preliminary results can be PRed but only after permission from Dana Farber. We don't know when that will be. But, so far trail updates have included cohort completions and advancement, but no data at all except to generally say no dose limiting toxicities.

So, if any preliminary results are announced ahead of ASCO, then details will probably discussed during q&a and private meetings.

[58nout]

JB, I agree but I also feel that unless there are investment minded folks in the family circles that they'll just be more hopeful about the future. What I mean to say is, except for an oncologist that I personally know, I've never met anyone who even knows what Kevetrin is all about.